QA: AILERON THERAPEUTICS INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001420565_2022_AILERON_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001420565')"}

Graph

Absolute values for 0001420565, AILERON THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 48,177,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 128,000
3 remainder_Assets 176,000
4 LiabilitiesCurrent 4,508,000
5 LiabilitiesNoncurrent 69,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,597,000
9 ResearchAndDevelopmentExpense 17,008,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 441,000
13 remainder_ComprehensiveNetIncome -11,000
  yvar yval
0 Assets 48,481,000
1 Liabilities 4,577,000
2 Expenses 26,605,000
3 Revenues 0
4 StockholdersEquity 43,904,000
5 NetIncome -26,164,000
6 ComprehensiveNetIncome -26,169,500
7 BaseVar 40,057,500
8 EconomicCapitalRatio 1.86

Edgar->Model Mapping

Feature Distribution

Change over Time